Lexaria Bioscience
LEXX
LEXX
20 hedge funds and large institutions have $1.49M invested in Lexaria Bioscience in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$320K | |
| 2 | +$75K | |
| 3 | +$37K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.72K |
Top Sellers
| 1 | -$889K | |
| 2 | -$40.4K | |
| 3 | -$13K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.15K |